These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 12153755

  • 1. Low-dose pharmacokinetics and oral bioavailability of dichloroacetate in naive and GST-zeta-depleted rats.
    Saghir SA, Schultz IR.
    Environ Health Perspect; 2002 Aug; 110(8):757-63. PubMed ID: 12153755
    [Abstract] [Full Text] [Related]

  • 2. Dichloroacetate toxicokinetics and disruption of tyrosine catabolism in B6C3F1 mice: dose-response relationships and age as a modifying factor.
    Schultz IR, Merdink JL, Gonzalez-Leon A, Bull RJ.
    Toxicology; 2002 May 01; 173(3):229-47. PubMed ID: 11960676
    [Abstract] [Full Text] [Related]

  • 3. Stereospecific toxicokinetics of bromochloro- and chlorofluoroacetate: effect of GST-zeta depletion.
    Schultz IR, Sylvester SR.
    Toxicol Appl Pharmacol; 2001 Sep 01; 175(2):104-13. PubMed ID: 11543642
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A quantitative description of suicide inhibition of dichloroacetic acid in rats and mice.
    Keys DA, Schultz IR, Mahle DA, Fisher JW.
    Toxicol Sci; 2004 Dec 01; 82(2):381-93. PubMed ID: 15375292
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of pre-treatment with dichloroacetic or trichloroacetic acid in drinking water on the pharmacokinetics of a subsequent challenge dose in B6C3F1 mice.
    Gonzalez-Leon A, Merdink JL, Bull RJ, Schultz IR.
    Chem Biol Interact; 1999 Dec 15; 123(3):239-53. PubMed ID: 10654841
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition and recovery of rat hepatic glutathione S-transferase zeta and alteration of tyrosine metabolism following dichloroacetate exposure and withdrawal.
    Guo X, Dixit V, Liu H, Shroads AL, Henderson GN, James MO, Stacpoole PW.
    Drug Metab Dispos; 2006 Jan 15; 34(1):36-42. PubMed ID: 16199472
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat.
    DeAngelo AB, Daniel FB, Most BM, Olson GR.
    Toxicology; 1996 Dec 18; 114(3):207-21. PubMed ID: 8980710
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A Mechanism-Based Pharmacokinetic Enzyme Turnover Model for Dichloroacetic Acid Autoinhibition in Rats.
    Jiang Y, Milavetz G, James MO, An G.
    J Pharm Sci; 2017 May 18; 106(5):1396-1404. PubMed ID: 28163135
    [Abstract] [Full Text] [Related]

  • 16. Exposure of Rats to Multiple Oral Doses of Dichloroacetate Results in Upregulation of Hepatic Glutathione Transferases and NAD(P)H Dehydrogenase [Quinone] 1.
    Squirewell EJ, Mareus R, Horne LP, Stacpoole PW, James MO.
    Drug Metab Dispos; 2020 Nov 18; 48(11):1224-1230. PubMed ID: 32873592
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Kinetics and effects of dichloroacetic acid in rainbow trout.
    Fitzsimmons PN, Hoffman AD, Lien GJ, Hammermeister DE, Nichols JW.
    Aquat Toxicol; 2009 Sep 14; 94(3):186-94. PubMed ID: 19656582
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of oral dichloroacetate in dogs.
    Maisenbacher HW, Shroads AL, Zhong G, Daigle AD, Abdelmalak MM, Samper IS, Mincey BD, James MO, Stacpoole PW.
    J Biochem Mol Toxicol; 2013 Dec 14; 27(12):522-5. PubMed ID: 24038869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.